Global Artemisinin Derivatives Market Is Expected To Reach Around USD 1,080 MN In 2027

The latest market report published by Credence Research, Inc. “Global Artemisinin Derivatives Market: Growth, Future Prospects, and Competitive Analysis, 2015 – 2027”. The Artemisinin Derivatives market was valued at USD 655 million in 2020 and expected to grow at a CAGR of 6.05% during the forecast period from 2021 to 2027 to reach around USD 1,080 million in 2027.

Artemisinin derivatives are a group of active pharmaceutical ingredients which are used in treatment against malaria. Artemisinin and its derivatives effectively fight against malarial and parasitic worm (helminth) infections. They have been proven to be most effective and potential drugs to kill the parasites and its life cycle. Artemisinin is typically derived from the plant Artemisia annua and sweet wormwood. Artemisia annua and sweet wormwood are long been used in traditional Chinese medicines.

Browse Full Report: 

Key Trends in Global Artemisinin Derivatives Market

Prevalence of Malaria to Strengthen Demand for Artemisinin Derivatives

According latest report of WHO, there was increase in number of malaria cases in 2019 as compared to 2018. WHO reported that the malaria cases increased to 229 million in 2019 from that of 228 million in 2018. African region occupied highest share in total number of cases globally. In 2019, African region alone accounted for over 90% share in total number of malaria cases reported globally. Nigeria, Tanzania, Congo, Mozambique, Niger and Burkina Faso reported 50% of all deaths occurred due to malaria across the world in 2019. This in turn driving the demand for Artemisinin Derivatives based API in treatment of uncomplicated as well as severe malaria.

Impact of COVID 19 on Global Artemisinin Derivatives Market

COVID 19 has left an unparalleled impact on growth of global Artemisinin Derivatives industry. The global Artemisinin Derivatives has witnessed very severe setback like never before. The demand for Artemisinin Derivatives is expected to be plunged by almost 20% in 2020, in terms of both volume as well as revenue. However, with the beginning of unlock process across the world and anticipation of COVID 19 vaccine to be launched during first half of 2020 is expected to bring recovery in demand for Artemisinin Derivatives.

Pre and Post COVID 19 Global Artemisinin Derivatives Market, 2019 – 2027 (USD Million)

Artemisinin Derivatives market

Global Artemisinin Derivatives Market by Type Insights

Based on its type, the global Artemisinin Derivatives market can be segmented into Dihydroartemisinin, Artemisunate and Others. Dihydroartemisinin segment has accounted for over 45% share in total revenue generated by Artemisinin Derivatives in 2020. Dihydroartemisinin is the active metabolite of all artemisinin compounds including artemisinin, artesunate, artemether, etc. Dihydroartemisinin can also be used as a drug in itself. Dihydroartemisinin is a semi-synthetic derivative of artemisinin and is broadly used as a midway while deriving other artemisinin-based API’s. In commercial market, it is sold in combination with piperaquine.

Global Artemisinin Derivatives Market by Application Insights

Based on its application, the global Artemisinin Derivatives market can be segmented into Malaria Treatment, Scientific Research and Others. Malaria Treatment segment dominated the global Artemisinin Derivatives demand in 2020 with over 60% share in total revenue generated by this industry. Ever rising malaria cases, increasing use of Artemisinin Derivatives in treatment of cancer, helminthiasis, and autoimmuno disease is mainly fueling growth of this industry. Artemisinin based API’s are currently being used in research laboratories for their capability to fight against cancer cells.

Global Artemisinin Derivatives Market by Regional Insights

North America accounted for largest share of over 35% in 2020 and was closely followed by the Europe and Asia Pacific. Africa and Latin America are likely post significant growth in demand for Artemisinin Derivatives over the forecast period. Easy availability of drugs, strong distribution network, high level of health awareness among people, government initiatives to irradicate various diseases, and string spending capacity of end-users is driving demand for Artemisinin Derivatives based drugs in North America and Europe. Asia Pacific is likely to exhibit fastest CAGR over the forecast period.

Global Artemisinin Derivatives Market Competitive Landscape

Key players operating in the field of manufacturing Artemisinin Derivatives including but not limited to Sanofi, KPC Pharmaceuticals, Guangxi Xiancaotang Pharmaceutical, Guilin Pharmaceutical, Kerui Nanhai Pharmaceutical, Shanghai Natural Bio-engineering Co, Novanat Bioresource, Botanical Extracts EPZ Ltd and others. Market share of memory foam mattress industry is moderately concentrated with large number of industry participants around the world. Top three players in Artemisinin Derivatives market accounted for around 40% share in 2020.

Market Segmentation

Global Artemisinin Derivatives Market by Type, 2015 – 2027

·       Dihydroartemisinin

·       Artemisunate

·       Others

Global Artemisinin Derivatives Market by Application, 2015 – 2027

·       Malaria Treatment

·       Scientific Research

·       Others

Global Artemisinin Derivatives Market by Region, 2015 – 2027

·       North America

·       Europe

·       Asia Pacific

·       Latin America

·       Middle East and Africa

Global Artemisinin Derivatives Market: Key Players

·       Sanofi

·       KPC Pharmaceuticals

·       Guangxi Xiancaotang Pharmaceutical

·       Guilin Pharmaceutical

·       Kerui Nanhai Pharmaceutical

·       Shanghai Natural Bio-engineering Co

·       Novanat Bioresource

·       Botanical Extracts EPZ Ltd

.       Ohers